About the Authors

Arrigo F. G. Cicero

Roles Conceptualization, Data curation, Writing – original draft, Writing – review & editing

arrigo.cicero@unibo.it (AFGC); maciejbanach77@gmail.com (MB)

Affiliation Hypertension and Cardiovascular Risk Factors Research Group, Department of Medicine and Surgery Sciences, University of Bologna, Bologna, Italy

Federica Fogacci

Roles Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing

Affiliation Hypertension and Cardiovascular Risk Factors Research Group, Department of Medicine and Surgery Sciences, University of Bologna, Bologna, Italy

Adrian V. Hernandez

Roles Data curation, Methodology, Writing – review & editing

Affiliations Health Outcomes, Policy, and Evidence Synthesis (HOPES) Group, University of Connecticut/Hartford Hospital Evidence-based Practice Center, Hartford, Connecticut, United States of America, Vicerrectorado de Investigacion, Universidad San Ignacio de Loyola, Lima, Peru

Maciej Banach

Roles Conceptualization, Project administration, Writing – original draft, Writing – review & editing

arrigo.cicero@unibo.it (AFGC); maciejbanach77@gmail.com (MB)

Affiliations Chair of Nephrology and Hypertension, Department of Hypertension, Medical University of Lodz, Lodz, Poland, Polish Mother’s Memorial Hospital Research Institute, Lodz, Poland, Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland

on behalf of the Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group and the International Lipid Expert Panel (ILEP)

Membership of the International Lipid Expert Panel (ILEP) is provided in the Acknowledgments.

Competing Interests

I have read the journal's policy and the authors of this manuscript have the following competing interests: MB has received research grant(s)/support from Sanofi and Valeant, and has served as a consultant for Abbott/Mylan, Akcea, Amgen, KRKA, MSD, Polfarmex, Polpharma, Sanofi-Aventis/Regeneron, Servier, Esperion, and Resverlogix. AFGC was scientific consultant for Mylan and Menarini International. FF was scientific consultant for Mylan. AH has no conflict of interest to declare.